List of Excipients in API clindamycin phosphate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing clindamycin phosphate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pharmacia & Upjohn Company LLC | CLEOCIN PHOSPHATE | clindamycin phosphate | 0009-0302 | BENZYL ALCOHOL | |
| Pharmacia & Upjohn Company LLC | CLEOCIN PHOSPHATE | clindamycin phosphate | 0009-0302 | EDETATE DISODIUM | |
| Pharmacia & Upjohn Company LLC | CLEOCIN PHOSPHATE | clindamycin phosphate | 0009-0302 | HYDROCHLORIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing clindamycin phosphate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 | CETOSTEARYL ALCOHOL |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 | GLYCERIN |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 | GLYCERYL MONOSTEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for clindamycin phosphate
Excipient focus: ALCOHOL
clindamycin phosphate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | clindamycin phosphate | 0378-8134 |
| Medimetriks Pharmaceuticals Inc | clindamycin phosphate | 43538-179 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-660 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALLANTOIN
clindamycin phosphate drug variants containing ALLANTOIN
| Company | Ingredient | NDC |
|---|---|---|
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-161 |
| Encube Ethicals Private Limited | clindamycin phosphate gel usp, 1% | 21922-027 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-900 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing ALLANTOIN
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
clindamycin phosphate drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
clindamycin phosphate drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| Baxter Healthcare Corporation | clindamycin phosphate | 0338-3410 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
clindamycin phosphate drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE A
clindamycin phosphate drug variants containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Oceanside Pharmaceuticals | clindamycin phosphate | 68682-462 |
| Amneal Pharmaceuticals NY LLC | clindamycin phosphate | 69238-2031 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
clindamycin phosphate drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-161 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-900 |
| A-S Medication Solutions | clindamycin phosphate | 50090-0768 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
clindamycin phosphate drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | clindamycin phosphate and benzoyl peroxide | 0187-3050 |
| Actavis Pharma Inc | clindamycin phosphate and benzoyl peroxide | 0591-3916 |
| Sandoz Inc | clindamycin phosphate and benzoyl peroxide | 0781-7161 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
clindamycin phosphate drug variants containing CETOSTEARYL ALCOHOL
clindamycin phosphate drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
clindamycin phosphate drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | clindamycin phosphate | 0378-8134 |
| Medimetriks Pharmaceuticals Inc | clindamycin phosphate | 43538-179 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-660 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL PALMITATE
clindamycin phosphate drug variants containing CETYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0277 |
| A-S Medication Solutions | clindamycin phosphate | 50090-1383 |
| Physicians Total Care Inc | clindamycin phosphate | 54868-5307 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing CETYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
clindamycin phosphate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Organon LLC | clindamycin phosphate | 78206-189 |
| Daré Bioscience Inc | clindamycin phosphate | 81505-100 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE MONOHYDRATE
clindamycin phosphate drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | clindamycin phosphate | 0338-3410 |
| Baxter Healthcare Corporation | clindamycin phosphate | 0338-3616 |
| Akorn | clindamycin phosphate | 17478-120 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
clindamycin phosphate drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | clindamycin phosphate and benzoyl peroxide | 0781-7161 |
| Encube Ethicals Private Limited | clindamycin phosphate and benzoyl peroxide | 21922-022 |
| Medimetriks Pharmaceuticals | clindamycin phosphate and benzoyl peroxide | 43538-176 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: DISODIUM LAURYL SULFOSUCCINATE
clindamycin phosphate drug variants containing DISODIUM LAURYL SULFOSUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | clindamycin phosphate and benzoyl peroxide | 0781-7161 |
| Taro Pharmaceuticals USA Inc | clindamycin phosphate and benzoyl peroxide | 51672-1366 |
| Bryant Ranch Prepack | clindamycin phosphate and benzoyl peroxide | 63629-8798 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing DISODIUM LAURYL SULFOSUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: DOCUSATE SODIUM
clindamycin phosphate drug variants containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | clindamycin phosphate and benzoyl peroxide | 0187-5190 |
| Oceanside Pharmaceuticals | clindamycin phosphate and benzoyl peroxide | 68682-190 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
clindamycin phosphate drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Baxter Healthcare Corporation | clindamycin phosphate | 0338-3410 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE SODIUM
clindamycin phosphate drug variants containing EDETATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | clindamycin phosphate and benzoyl peroxide | 70710-1445 |
| Zydus Lifesciences Limited | clindamycin phosphate and benzoyl peroxide | 70771-1450 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing EDETATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
clindamycin phosphate drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-246 |
| Encube Ethicals Private Limited | clindamycin phosphate | 21922-036 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL ISOSTEARATE
clindamycin phosphate drug variants containing GLYCERYL ISOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing GLYCERYL ISOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
clindamycin phosphate drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| Physicians Total Care Inc | clindamycin phosphate | 54868-4806 |
| Ther-Rx Corporation | clindamycin phosphate | 64011-124 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL STEARATE SE
clindamycin phosphate drug variants containing GLYCERYL STEARATE SE
| Company | Ingredient | NDC |
|---|---|---|
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-246 |
| Encube Ethicals Private Limited | clindamycin phosphate | 21922-036 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-128 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing GLYCERYL STEARATE SE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
clindamycin phosphate drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Baxter Healthcare Corporation | clindamycin phosphate | 0338-3410 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
clindamycin phosphate drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
clindamycin phosphate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| Marlex Pharmaceuticals Inc | clindamycin phosphate | 10135-691 |
| Rebel Distributors Corp | clindamycin phosphate | 21695-888 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOSTEARYL ALCOHOL
clindamycin phosphate drug variants containing ISOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-246 |
| Encube Ethicals Private Limited | clindamycin phosphate | 21922-036 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing ISOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: LAURETH-4
clindamycin phosphate drug variants containing LAURETH-4
| Company | Ingredient | NDC |
|---|---|---|
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing LAURETH-4
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
clindamycin phosphate drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| Ther-Rx Corporation | clindamycin phosphate | 64011-124 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
clindamycin phosphate drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-161 |
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-246 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE WAX
clindamycin phosphate drug variants containing MICROCRYSTALLINE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing MICROCRYSTALLINE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
clindamycin phosphate drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0277 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 124
clindamycin phosphate drug variants containing POLOXAMER 124
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | clindamycin phosphate and benzoyl peroxide | 51672-1367 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POLOXAMER 124
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 182
clindamycin phosphate drug variants containing POLOXAMER 182
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | clindamycin phosphate and benzoyl peroxide | 0781-7161 |
| Encube Ethicals Private Limited | clindamycin phosphate and benzoyl peroxide | 21922-022 |
| Taro Pharmaceuticals USA Inc | clindamycin phosphate and benzoyl peroxide | 51672-1366 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POLOXAMER 182
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
clindamycin phosphate drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Organon LLC | clindamycin phosphate | 78206-189 |
| Daré Bioscience Inc | clindamycin phosphate | 81505-100 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
clindamycin phosphate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-161 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-900 |
| A-S Medication Solutions | clindamycin phosphate | 50090-0768 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-3 OLEATE
clindamycin phosphate drug variants containing POLYGLYCERYL-3 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POLYGLYCERYL-3 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 60
clindamycin phosphate drug variants containing POLYSORBATE 60
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0277 |
| Mylan Pharmaceuticals Inc | clindamycin phosphate | 0378-8134 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POLYSORBATE 60
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
clindamycin phosphate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
clindamycin phosphate drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | clindamycin phosphate | 0378-8134 |
| Bausch Health US LLC | clindamycin phosphate and benzoyl peroxide | 0187-3050 |
| Actavis Pharma Inc | clindamycin phosphate and benzoyl peroxide | 0591-3916 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
clindamycin phosphate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0277 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
clindamycin phosphate drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| Ther-Rx Corporation | clindamycin phosphate | 64011-124 |
| Medimetriks Pharmaceuticals | clindamycin phosphate and benzoyl peroxide | 43538-176 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
clindamycin phosphate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| Ther-Rx Corporation | clindamycin phosphate | 64011-124 |
| Encube Ethicals Private Limited | clindamycin phosphate and benzoyl peroxide | 21922-022 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
clindamycin phosphate drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | clindamycin phosphate | 0338-9545 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
clindamycin phosphate drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Daré Bioscience Inc | clindamycin phosphate | 81505-100 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
clindamycin phosphate drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Baxter Healthcare Corporation | clindamycin phosphate | 0338-3410 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAUROYL SARCOSINATE
clindamycin phosphate drug variants containing SODIUM LAUROYL SARCOSINATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| NORTHSTAR RX LLC | clindamycin phosphate | 16714-246 |
| Encube Ethicals Private Limited | clindamycin phosphate | 21922-036 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing SODIUM LAUROYL SARCOSINATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOSTEARATE
clindamycin phosphate drug variants containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0277 |
| A-S Medication Solutions | clindamycin phosphate | 50090-1383 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
clindamycin phosphate drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-042 |
| Ther-Rx Corporation | clindamycin phosphate | 64011-124 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
clindamycin phosphate drug variants containing STEARIC ACID
clindamycin phosphate drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
clindamycin phosphate drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | clindamycin phosphate | 0378-8134 |
| Medimetriks Pharmaceuticals Inc | clindamycin phosphate | 43538-179 |
| Padagis Israel Pharmaceuticals Ltd | clindamycin phosphate | 45802-660 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
clindamycin phosphate drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Organon LLC | clindamycin phosphate | 78206-189 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE
clindamycin phosphate drug variants containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
clindamycin phosphate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3448 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | clindamycin phosphate | 0168-0203 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Henry Schein Inc | clindamycin phosphate | 0404-9837 |
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE WAX
clindamycin phosphate drug variants containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Ther-Rx Corporation | clindamycin phosphate | 64011-124 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
clindamycin phosphate drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Organon LLC | clindamycin phosphate | 78206-189 |
| Daré Bioscience Inc | clindamycin phosphate | 81505-100 |
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-0302 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3051 |
| Pharmacia & Upjohn Company LLC | clindamycin phosphate | 0009-3116 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
